These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28738086)

  • 1. An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.
    Pei Y; Banerjee S; Jha HC; Sun Z; Robertson ES
    PLoS Pathog; 2017 Jul; 13(7):e1006500. PubMed ID: 28738086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.
    Sun K; Bose D; Singh RK; Pei Y; Robertson ES
    J Virol; 2024 Jul; 98(7):e0054824. PubMed ID: 38864622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
    PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
    Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
    Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
    J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.
    Pei Y; Banerjee S; Sun Z; Jha HC; Saha A; Robertson ES
    PLoS Pathog; 2016 Aug; 12(8):e1005844. PubMed ID: 27548379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
    Saha A; Bamidele A; Murakami M; Robertson ES
    J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
    PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
    Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
    PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.
    Banerjee S; Lu J; Cai Q; Sun Z; Jha HC; Robertson ES
    PLoS Pathog; 2014 Aug; 10(8):e1004304. PubMed ID: 25121590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
    Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.
    Saha A; Lu J; Morizur L; Upadhyay SK; Aj MP; Robertson ES
    PLoS Pathog; 2012; 8(3):e1002573. PubMed ID: 22438805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
    Saha A; Halder S; Upadhyay SK; Lu J; Kumar P; Murakami M; Cai Q; Robertson ES
    PLoS Pathog; 2011 Feb; 7(2):e1001275. PubMed ID: 21347341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
    Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
    PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.